• SELECT SITE CURRENCY
Select a currency for use throughout the site
Global Neuromodulation Market 2009-2013
Infiniti Research Limited, February 2010, Pages: 19
Neuromodulation consist of devices, which are implantable, wireless controlled and delivers electrical current at targeted nerve fibers, to treat a patient's disabling neurological condition. It addresses the needs of the various neurological disorders, nervous system ailments and psychiatric illnesses. It is widely used for the treatment of chronic conditions such as lower back pain, urinary incontinence, Parkinson's disease, tremor, epilepsy, depression, etc.
Advancement in technology and greater knowledge in neurophysiology offers vast potential opportunities in new treatments, leveraging tremendous growth of the Neuromodulation market. The Neuromodulation market is rapidly growing as it addresses a huge patient population in epilepsy, depression, stroke, anxiety disorders, Parkinson’s disease, etc. With this rapid growth, the market for Neuromodulation market is expected to become as large as the cardiac devices market. Further, the competition among the companies, emergence of new treatments, and the increasing patient population is expected to account for the growth of novel markets within the Neuromodulation field. In addition, the advances in technology and neuroscience pose potential opportunities for developing effective therapies for various neurological disorders.
The report forecasts the market size of the worldwide Neuromodulation market over the period 2009-2013. Further, the report discusses about the segmentation of the Neuromodulation market into various geographic regions. It also identifies the major market trends, drivers, and challenges existing for the Neuromodulation market.
2. Neuromodulation Market Size & Forecast
3. Geographic Segmentation
3.1 Neuromodulation Market in Americas
3.2 Neuromodulation Market in EMEA
3.3 Neuromodulation Market in APAC
4. Market Trends of Neuromodulation
5. Sales Drivers of Neuromodulation
6. Market Challenges for Neuromodulation
7. Neuromodulation Market Vendors
7.1 Boston Scientific Corporation
7.2 Cyberonics, Inc.
7.3 Johnson & Johnson
7.4 Medtronic, Inc
7.5 St. Jude Medical, Inc
Other Reports in this Series
List of Exhibits
Exhibit 2.1: Neuromodulation Market Size and Forecast 2009-2013 (In $ million)
Exhibit 3.1: Neuromodulation Market Segmentation by Geography -2009
Exhibit 3.2: Americas Neuromodulation Market Size 2009-2013 (in $ million)
Exhibit 3.3: EMEA Neuromodulation Market Size 2009-2013 (in $ million)
Exhibit 3.4: APAC Neuromodulation Market Size 2009-2013 (in $ million)
- Boston Scientific Corporation
- Cyberonics, Inc
- Johnson & Johnson
- Medtronic, Inc
A sample for this product is available. Please Login/Register to download this sample.